CN1043647C - 新的肽化合物 - Google Patents

新的肽化合物 Download PDF

Info

Publication number
CN1043647C
CN1043647C CN92103241A CN92103241A CN1043647C CN 1043647 C CN1043647 C CN 1043647C CN 92103241 A CN92103241 A CN 92103241A CN 92103241 A CN92103241 A CN 92103241A CN 1043647 C CN1043647 C CN 1043647C
Authority
CN
China
Prior art keywords
group
compound
salt
low
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92103241A
Other languages
English (en)
Chinese (zh)
Other versions
CN1066660A (zh
Inventor
高杉寿
田中明人
酒井裕义
石川贵敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919110298A external-priority patent/GB9110298D0/en
Priority claimed from GB929202260A external-priority patent/GB9202260D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CN1066660A publication Critical patent/CN1066660A/zh
Application granted granted Critical
Publication of CN1043647C publication Critical patent/CN1043647C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN92103241A 1991-05-13 1992-05-12 新的肽化合物 Expired - Fee Related CN1043647C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9110298.8 1991-05-13
GB919110298A GB9110298D0 (en) 1991-05-13 1991-05-13 New peptide compound and a process for the preparation thereof
GB9202260.7 1992-02-03
GB929202260A GB9202260D0 (en) 1992-02-03 1992-02-03 New peptide compound and a process for the preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN95109813A Division CN1120047A (zh) 1991-05-13 1995-08-18 新的肽化合物及其制备方法

Publications (2)

Publication Number Publication Date
CN1066660A CN1066660A (zh) 1992-12-02
CN1043647C true CN1043647C (zh) 1999-06-16

Family

ID=26298895

Family Applications (2)

Application Number Title Priority Date Filing Date
CN92103241A Expired - Fee Related CN1043647C (zh) 1991-05-13 1992-05-12 新的肽化合物
CN95109813A Pending CN1120047A (zh) 1991-05-13 1995-08-18 新的肽化合物及其制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN95109813A Pending CN1120047A (zh) 1991-05-13 1995-08-18 新的肽化合物及其制备方法

Country Status (15)

Country Link
US (1) US5574016A (enExample)
EP (1) EP0513675B1 (enExample)
JP (1) JP2606528B2 (enExample)
KR (1) KR920021579A (enExample)
CN (2) CN1043647C (enExample)
AT (1) ATE142641T1 (enExample)
AU (1) AU662522B2 (enExample)
CA (1) CA2068478A1 (enExample)
DE (1) DE69213546T2 (enExample)
DK (1) DK0513675T3 (enExample)
ES (1) ES2091359T3 (enExample)
GR (1) GR3021182T3 (enExample)
HU (2) HUT61780A (enExample)
IL (1) IL101839A (enExample)
TW (1) TW203057B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272162A (en) * 1992-07-02 1993-12-21 G. D. Searle & Co. Platelet aggregation inhibitors
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors
US5314902A (en) * 1993-01-27 1994-05-24 Monsanto Company Urea derivatives useful as platelet aggregation inhibitors
DE4309867A1 (de) * 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
EP0690847A1 (en) * 1993-03-29 1996-01-10 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
WO1995013825A1 (en) * 1993-11-19 1995-05-26 G.D. Searle & Co. TRANSDERMAL COMPOSITION OF N-[N-[5-[4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-α-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
US6387880B1 (en) 1994-10-24 2002-05-14 G.D. Searle & Co. Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L-α-aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts
WO1996013497A1 (en) * 1994-11-01 1996-05-09 Terumo Kabushiki Kaisha Tetrahydroisoquinoline derivative and medicinal preparation containing the same
SK281432B6 (sk) * 1995-12-20 2001-03-12 Hoechst Marion Roussel, Inc. Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2
US5766932A (en) * 1995-12-20 1998-06-16 Hoechst Marion Roussel, Inc. Process for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisin
JP2001131078A (ja) * 1999-11-09 2001-05-15 Iatron Lab Inc 新規活性固定化血小板及びその製造方法
DE10005631A1 (de) * 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
JP5089845B2 (ja) * 2000-09-06 2012-12-05 エミスフェアー・テクノロジーズ・インク シアノフェノキシカルボン酸化合物および活性薬剤送達用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
AU646838B2 (en) * 1990-03-09 1994-03-10 F. Hoffmann-La Roche Ag Acetic acid derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5481021A (en) * 1991-03-06 1996-01-02 G. D. Searle & Co. Phenyl amidines derivatives useful as platelet aggregation inhibitors
DE4212304A1 (de) * 1992-04-13 1993-10-14 Cassella Ag Asparaginsäurederivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
TW203057B (enExample) 1993-04-01
JP2606528B2 (ja) 1997-05-07
IL101839A0 (en) 1992-12-30
JPH05148207A (ja) 1993-06-15
DE69213546D1 (de) 1996-10-17
EP0513675A1 (en) 1992-11-19
AU1614492A (en) 1992-11-19
KR920021579A (ko) 1992-12-18
DE69213546T2 (de) 1997-02-27
DK0513675T3 (da) 1996-09-30
HU211266A9 (en) 1995-11-28
ES2091359T3 (es) 1996-11-01
HUT61780A (en) 1993-03-01
CN1066660A (zh) 1992-12-02
CA2068478A1 (en) 1992-11-14
US5574016A (en) 1996-11-12
HU9201578D0 (en) 1992-08-28
IL101839A (en) 1996-12-05
CN1120047A (zh) 1996-04-10
ATE142641T1 (de) 1996-09-15
AU662522B2 (en) 1995-09-07
GR3021182T3 (en) 1996-12-31
EP0513675B1 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
CN1120047A (zh) 新的肽化合物及其制备方法
CN1040541C (zh) 新型多肽化合物的制备方法
CN1149210C (zh) 凝血酶抑制剂
CN1168675A (zh) 新化合物
CN1034869C (zh) 肽类化合物及其可药用盐的制备方法
CN1022187C (zh) 三环化合物的制备方法
CN1041941A (zh) 苯并二氮杂衍生物的制备方法
CN1505617A (zh) 作为Met-AP2抑制剂的肽
CN1067883A (zh) 纤维蛋白原受体拮抗剂
CN1076345C (zh) 2,3－二氨基丙酸衍生物
CN1214011C (zh) 作为整联蛋白拮抗剂的间－氮杂环氨基苯甲酸化合物及其衍生物
CN101077875A (zh) 硼酸酯和硼酸化合物,其合成和应用
CN1174504A (zh) 促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
CN1192729A (zh) 苯甲酰胺衍生物和它们作为后叶加压素拮抗剂的应用
CN1037156A (zh) 肽类化合物、其制备方法及含有这类化合物的药物组合物
CN1211991A (zh) 具有生长激素释放性质的化合物
CN87101164A (zh) 次膦酸衍生物
CN1356995A (zh) 取代的苯并咪唑
CN1170409A (zh) 新的2,3－二氧代哌嗪衍生物及其盐
CN1066150C (zh) 作为基质金属蛋白酶抑制剂的桥式吲哚
CN1290254A (zh) 氨磺酰衍生物及其制备和用途
CN1041919C (zh) 用作血小板激活因子拮抗物的N-(3-哌啶基碳酰)-β-氨基丙酸衍生物
CN1169986A (zh) 2,9－二氨基和2－氨基－8－氨基甲酰基－4－羟基－链烷酸酰胺衍生物
CN1097192A (zh) 逆转录酶病毒蛋白酶抑制剂
CN1204889C (zh) 粘附受体拮抗剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee